The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease
Open accessAbstract
BACKGROUND: Clinical studies suggest that inhaled corticosteroids reduce exacerbations and improve health status in chronic obstructive pulmonary disease (COPD). However, their effect on mortality is unknown. METHODS: A pooled analysis, based on intention to treat, of individual patient data from seven randomised trials (involving 5085 patients) was performed in which the effects of inhaled corticosteroids and placebo were compared over at least 12 months in patients with stable COPD. The end point was all-cause mortality. RESULTS: Overall, 4% of the participants died during a mean follow up period of 26 months. Inhaled corticosteroids reduced all-cause mortality by about 25% relative to placebo. Stratification by individual trials and adjustments for age, sex, baseline post-bronchodilator percentage predicted forced expiratory volume in 1 second, smoking status, and body mass index did not materially change the results (adjusted hazard ratio (HR) 0.73; 95% confidence interval (CI) 0.55 to 0.96). Although there was considerable overlap between subgroups in terms of effect sizes, the beneficial effect was especially noticeable in women (adjusted HR 0.46; 95% CI 0.24 to 0.91) and former smokers (adjusted HR 0.60; 95% CI 0.39 to 0.93). CONCLUSIONS: Inhaled corticosteroids reduce all-cause mortality in COPD. Further studies are required to determine whether the survival benefits persist beyond 2-3 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationMurray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Spirometric Reference Values from a Sample of the General U.S. Population
HANKINSON, J. L., ODENCRANTZ, J. R., & FEDAN, K. B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9712108 · Cited by 4,206
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Barnes, P. J., Shapiro, S. D., & Pauwels, R. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00040703 · Cited by 1,439
Calverley, P., Pauwels, R., Vestbo, J., Jones, P., Pride, N., Gulsvik, A., Anderson, J., & Maden, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12459-2 · Cited by 1,221
Pauwels, R. A., Löfdahl, C.-G., Laitinen, L. A., Schouten, J. P., Postma, D. S., Pride, N. B., & Ohlsson, S. V. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402503 · Cited by 1,074
Szafranski, W., Cukier, A., Ramirez, A., Menga, G., Sansores, R., Nahabedian, S., Peterson, S., & Olsson, H. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00031402 · Cited by 887
(2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432601 · Cited by 830
Vestbo, J., Søorensen, T., Lange, P., Brix, A., Torre, P., & Viskum, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10019-3 · Cited by 816
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
Calverley, P. M., Boonsawat, W., Cseke, Z., Zhong, N., Peterson, S., & Olsson, H. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00027003 · Cited by 730
Mortality after hospitalization for COPD
Almagro, P., Calbo, E., Ochoa de Echaguïen, A., Barreiro, B., Quintana, S., Heredia, J. L., & Garau, J. (2002) · Chest · doi:10.1378/chest.121.5.1441 · Cited by 630
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Keatings, V. M., Jatakanon, A., Worsdell, Y. M., & Barnes, P. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032192 · Cited by 558
Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma
Chalmers, G. W. (2002) · Thorax · doi:10.1136/thorax.57.3.226 · Cited by 545
Impact of preventing exacerbations on deterioration of health status in COPD
Spencer, S., Calverley, P. M. A., Burge, P. S., & Jones, P. W. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00121404 · Cited by 441
Epidemiology of chronic obstructive pulmonary disease
Antó, J. M., Vermeire, P., Vestbo, J., & Sunyer, J. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17509820 · Cited by 427
CULPITT, S. V., MAZIAK, W., LOUKIDIS, S., NIGHTINGALE, J. A., MATTHEWS, J. L., & BARNES, P. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9811058 · Cited by 417
Domingo-Salvany, A., Lamarca, R., Ferrer, M., Garcia-Aymerich, J., Alonso, J., Félez, M., Khalaf, A., Marrades, R. M., Monsó, E., Serra-Batlles, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112043 · Cited by 411
Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review
Sin, D. D., McAlister, F. A., Man, S. F. P., & Anthonisen, N. R. (2003) · JAMA · doi:10.1001/jama.290.17.2301 · Cited by 404
Self-citationBarnes, P. J., Ito, K., & Adcock, I. M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15650-x · Cited by 399
Ongoing airway inflammation in patients with COPD who do not currently smoke
Rutgers, S. R. (2000) · Thorax · doi:10.1136/thorax.55.1.12 · Cited by 398
Dose-dependent cigarette smoking-related inflammatory responses in healthy adults
Kuschner, W., D'Alessandro, A., Wong, H., & Blanc, P. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09101989 · Cited by 371
Alsaeedi, A., Sin, D. D., & McAlister, F. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01143-9 · Cited by 326
Self-citationJones, P. W., Willits, L. R., Burge, P. S., & Calverley, P. M. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00013303 · Cited by 249
Hospers, J. J., Postma, D. S., Rijcken, B., Weiss, S. T., & Schouten, J. P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02815-4 · Cited by 221
Sutherland, E. R. (2003) · Thorax · doi:10.1136/thorax.58.11.937 · Cited by 220
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study.
Kanner, R. E., Connett, J. E., Altose, M. D., Buist, A. S., Lee, W. W., Tashkin, D. P., & Wise, R. A. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921469 · Cited by 201
Pedersen, B., Dahl, R., Karlström, R., Peterson, C. G. B., & Venge, P. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.5.8630596 · Cited by 182
Cyclooxygenase as a Target in Lung Cancer
Brown, J. R., & DuBois, R. N. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-040014 · Cited by 160
Burge, P. S. (2003) · Thorax · doi:10.1136/thorax.58.8.654 · Cited by 153
Maestrelli, P., MESSLEMANI, A. H. E., Fina, O. D., Nowicki, Y., Saetta, M. P., Mapp, C. E., & Fabbri, L. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.8.2011083 · Cited by 125
Lam, S. C., LeRiche, J., McWilliams, A. M., MacAulay, C. E., Dyachkova, Y., Szabo, E. M., Mayo, J. R., Schellenberg, R. R., Coldman, A., Hawk, E. T., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0686 · Cited by 124
Inflammation as Cause for Scar Cancers of the Lung
Ardies, C. M. (2003) · Integrative Cancer Therapies · doi:10.1177/1534735403256332 · Cited by 120
Ongoing Airway Inflammation in Patients With COPD Who Do Not Currently Smoke
Rutgers, S. R., Postma, D. S., ten Hacken, N. H. T., Kauffman, H. F., van der Mark, T. W., Koëter, G. H., & Timens, W. (2000) · CHEST Journal · doi:10.1378/chest.117.5_suppl_1.262s · Cited by 113
Withdrawal From Treatment as an Outcome in the ISOLDE Study of COPD
Calverley, P. M. A., Spencer, S., Willits, L. R., Burge, P. S., & Jones, P. (2003) · CHEST Journal · doi:10.1378/chest.124.4.1350 · Cited by 108
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationRabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00099306 · Cited by 858
Metadata
- Authors
- Sin, D. D.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2005-12-01
- Volume
- 60
- Issue
- 12
- Pages
- 992-997
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2108426443
- Cited by
- 307
- References
- 36
- FWCI
- 35.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.